Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults-Reference-Cited by-同舟云学术

Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

Published:2016-06 Issue:6 Volume:34 Page:361-371
ISSN:0213-005X
Container-title:Enfermedades Infecciosas y Microbiología Clínica
language:en
Short-container-title:Enfermedades Infecciosas y Microbiología Clínica

Author:

Berenguer Juan,Rivero Antonio,Blasco Antonio Javier,Arribas José Ramón,Boix Vicente,Clotet Bonaventura,Domingo Pere,González-García Juan,Knobel Hernando,Lázaro Pablo,López Juan Carlos,Llibre Josep M.,Lozano Fernando,Miró José M.,Podzamczer Daniel,Tuset Montserrat,Gatell Josep M.

Funder

Grupo de Estudio del SIDA (AIDS Study Group, GESIDA) of the Sociedad Española de Enfermedades Infecciosas y Microbiología Cínica

Red de Investigación en SIDA

Publisher

Elsevier BV

Subject

Microbiology (medical)

Reference55 articles.

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators;Palella;N Engl J Med,1998

2. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group;Mocroft;Lancet,1998

3. Survival of persons with and without HIV infection in Denmark, 1995–2005;Lohse;Ann Intern Med,2007

4. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study;May;BMJ,2011

5. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease;Autran;Science,1997

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010–2015;Enfermedades Infecciosas y Microbiología Clínica;2019-11

2. Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010–2015;Enfermedades infecciosas y microbiologia clinica (English ed.);2019-11

3. Durability of first-line antiretroviral regimens in the era of integrase inhibitors: a cohort of HIV-positive individuals in Spain, 2014–2015;Antiviral Therapy;2019

4. Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain;PLOS ONE;2018-11-05

5. Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults;Enfermedades Infecciosas y Microbiología Clínica;2018-05